VioQuest Pharmaceuticals, Inc. Summary of 2007 Management Bonus Plans
Contract Categories:
Human Resources
- Bonus & Incentive Agreements
EX-10.1 2 v081167_ex10-1.htm Unassociated Document
Exhibit 10.1
VioQuest Pharmaceuticals, Inc.
Summary of 2007 Management Bonus Plans
| Daniel Greenleaf (President & CEO) | Maximum Amount | |||
| Completion of financing resulting in proceeds of a targeted amount. | $ | 40,000 | ||
| Listing of the Company’s Common Stock on a national securities exchange | 50,000 | |||
| Achievement of clinical/regulatory milestones | 65,000 | |||
| The acquisition of a compound as approved by the Board of Directors. | 30,000 | |||
| Sale of Chiral Quest, Inc. | 40,000 | |||
| Qualitative: Company Values: Candor, Boundarylessness, Speed of Action, Patient Centricity, Risk Taking, Accountability, People Development, Financial Discipline | 25,000 | |||
| Total | $ | 250,000 | ||
| Edward Bradley, M.D. (Chief Scientific Officer) | Maximum Amount | |||
| Achievement of pre-determined clinical/regulatory milestones | $ | 82,800 | ||
| Qualitative: Company Values: Candor, Boundarylessness, Speed of Action, Patient Centricity, Risk Taking, Accountability, People Development, Financial Discipline | 9,200 | |||
| Total | $ | 92,000 | ||
| Brian Lenz (Chief Financial Officer) | Maximum Amount | |||
| Completion of financing resulting in proceeds of a targeted amount. | $ | 11,100 | ||
| List Listing of the Company’s Common Stock on a national securities exchange | 16,650 | |||
| Achievement of clinical/regulatory milestones | 5,550 | |||
| Sale of Chiral Quest, Inc. | 16,650 | |||
| Qualitative: Company Values: Candor, Boundarylessness, Speed of Action, Patient Centricity, Risk Taking, Accountability, People Development, Financial Discipline | 5,550 | |||
| Total | $ | 55,500 | ||
